Arkolith/Insider Trading/RMD/Form 4

Farrell Michael J.

Chairman and CEO, DirectorRESMED INC (RMD) · full profile →Form 4 · filed Nov 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 7, 2025Option exercise(M)7K$101.64$714K476K
Nov 7, 2025Option exercise(M)983$101.64$100K469K
Nov 7, 2025Sell(S)8K$249.75$2.0M468K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 7, 2025Option exercise(M)983—$07K
Nov 7, 2025Option exercise(M)7K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000943819-25-000095) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML